Literature DB >> 9786651

Pre-steady-state kinetic characterization of RNA-primed initiation of transcription by HIV-1 reverse transcriptase and analysis of the transition to a processive DNA-primed polymerization mode.

S H Thrall1, R Krebs, B M Wöhrl, L Cellai, R S Goody, T Restle.   

Abstract

Single-turnover and equilibrium measurements were carried out to determine the basis of the apparently slow, nonprocessive polymerization reaction catalyzed by HIV-1 reverse transcriptase (RT) during transcription initiation, when both the primer and template are composed of RNA. Comparison of the binding and kinetic parameters of a 20-mer, all-RNA primer/35-mer template substrate to one identical in sequence but composed of a 20-mer, all-DNA primer/35-mer RNA template reveals striking differences. Equilibrium titrations yielded a dissociation constant (Kd) >200 nM for the RNA/RNA-RT complex which is at least 200-fold higher than that of the DNA/RNA-substrate (Kd approximately 1 nM). The affinity of the RT-RNA/RNA complex for dTTP was found to be at least 500 times lower (Kd approximately 3.4 mM) than that of the RT-DNA/RNA complex (Kd approximately 6.6 microM). The single-turnover dNTP incorporation time course using the RNA-primer substrate, the DNA-primer substrate, or a series of RNA-primer substrates preextended with one to eight deoxynucleotides showed that dNTP incorporation occurs with a biphasic exponential burst of +1 extension product, followed by a linear phase. At least three different RT-bound forms of the p/ts exist: a fast, kinetically competent form (single-turnover rate approximately 10-50 s-1); a slow form (rate approximately 0.3-1 s-1); and a form that is dead-end (no turnover). The studies further revealed that a switch to a fast, kinetically competent p/t occurs after six dNTPs are incorporated into the RNA primer, with the switch being defined as the transition from a minority to a majority of the p/t bound in the optimal manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9786651     DOI: 10.1021/bi981102t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription.

Authors:  C W Hooker; W B Lott; D Harrich
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Assembly, purification and crystallization of an active HIV-1 reverse transcriptase initiation complex.

Authors:  Janice D Pata; Bradford R King; Thomas A Steitz
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

4.  Requirements for minus-strand transfer catalyzed by Rous sarcoma virus reverse transcriptase.

Authors:  S Werner; K Vogel-Bachmayr; B Hollinderbäumer; B M Wöhrl
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.

Authors:  Laurent Chaloin; Maik Jörg Lehmann; Georg Sczakiel; Tobias Restle
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

6.  Single-molecule study of DNA polymerization activity of HIV-1 reverse transcriptase on DNA templates.

Authors:  Sangjin Kim; Charles M Schroeder; X Sunney Xie
Journal:  J Mol Biol       Date:  2009-12-04       Impact factor: 5.469

7.  Styrylquinolines, integrase inhibitors acting prior to integration: a new mechanism of action for anti-integrase agents.

Authors:  Sabine Bonnenfant; Claire Marie Thomas; Claudio Vita; Frédéric Subra; Eric Deprez; Fatima Zouhiri; Didier Desmaële; Jean D'Angelo; Jean François Mouscadet; Hervé Leh
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

8.  The role of template-primer in protection of reverse transcriptase from thermal inactivation.

Authors:  Gary F Gerard; R Jason Potter; Michael D Smith; Kim Rosenthal; Gulshan Dhariwal; Jun Lee; Deb K Chatterjee
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

9.  Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity.

Authors:  Karidia Diallo; Bruno Marchand; Xin Wei; Luciano Cellai; Matthias Götte; Mark A Wainberg
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate.

Authors:  Guangwei Yang; Jimin Wang; Yao Cheng; Ginger E Dutschman; Hiromichi Tanaka; Masanori Baba; Yung-Chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.